We conduct research within clinical studies of acute poisonings, in particular regarding epidemiology, new diagnostic methods, treatment, complications and prognosis.
Alzheimer’s disease is the most common cause of age-related dementia, and a major societal problem due to the lack of efficacious therapeutics.
This research group is focused on transport and cycling of neurotransmitters and amino acids.
We aim to contribute with increased knowledge within the field of ophthalmology. Our research projects include glaucoma and diseases, as well as conditions related to the cornea and the lens.
The purpose of the research is a better understanding of the close interplay nutrition and atherosclerosis.
The main focus of the Autophagy group led by Anne Simonsen is to elucidate the mechanisms involved in recognition and clearance of cellular components by autophagy and characterize their roles in disease development, specifically tumor biology.
Dysfunctional autophagy is linked to several pathophysiological conditions, including cancer and neurodegenerative disorders. The main focus of the “Simonsen Lab” is to characterize of the molecular mechanisms involved in cargo sequestration and autophagosome biogenesis during non-selective and selective types of autophagy with a long-term goal to identify novel targets for diagnosis or treatment of human disease.
The aim of this research group is to explore metabolic aberrations in endocrine diseases for the identification and validation of new biomarkers.
The group investigates biological mechanisms in severe mental disorders to increase the knowledge of these disorders with potential implications for prevention, treatment, course prediction and diagnostics.
Blood cells have various tasks. We study mechanisms regulating inflammation and coagulation, with focus on extracellular vesicles.
Health problems are largely about change in function, and not just about symptoms and diagnoses. Our ambition is to perform different types of research projects as contributions to increase the knowledge about, and understanding of the links between, illness, health and function.
The overall goals of the research group are 1) to increase our knowledge of adult brain plasticity and its roles in neurological and psychiatric disorders and 2) to bridge the gap between neurological and psychiatric research.
Our research group focus on treatment, prognostication and outcome after critical conditions for the heart and the brain.
By studying the subcellular localisation and the functions of the splice variants of PKA (cAMP-dependent protein kinase), we will better understand the specificity in the cAMP-PKA pathway and their potential association with disease.
The molecular cancer medicine group is supervised by Jorrit Enserink and Helene Knævelsrud. The research group consists of people from eleven different countries, and currently consists of the group leader, two senior researcher, seven post-docs, three PhD students and a varying number of undergraduate students. We make use of model organisms as well as primary material from cancer patients to study several basic problems in cancer.
Sudden cardiac death due to cardiac arrhythmia is one of the most common causes of death in Norway. In young people it is often caused by a hereditary heart disease.
The research group is primarily engaged in researcher initiated studies of hypertension as a risk factor for cardiovascular and renal disease. We want to improve our understanding of the patients' perspectives by investigating new methods to improve adherence to antihypertensive medications.
The Cardiovascular Research Group (CRG) conducts high-quality, translational and clinical-epidemiological research with the overarching aim to promote personalized therapy in cardiovascular medicine.
Our main focus is methodological research in causal inference and event history analysis with applications to observational and randomized studies in epidemiology and medicine.
We do research on venous thrombosis and malignant hematological diseases. Our main focus are clinical trials of venous thrombosis, chronic lymphatic leukemia, and acute myeloid leukemia in elderly.
The main goal of the research group, is to elucidate the mechanisms involved in cAMP-mediated regulation of proliferation and apoptosis in cells of the immune system, in order to identify new targets for improved therapy of cancer
We work on uncovering and understanding novel mechanisms of autophagy termination, using Drosophila as a model.
Our research group's main goal is to better understand basic molecular and cellular adaptive immunology, and to translate this knowledge into improved vaccines and treatments against infectious diseases and cancer.
We study the connections between membrane dynamics and cancer development. Many of the crucial biochemical reactions in the cell take place at the cell's membranes - the plasma membrane or the membranes of the cell's organelles. These membranes are highly dynamic and undergo continuous budding, fission and remodeling, and alterations in membrane dynamics can affect biochemical reactions. In our group we try to identify dysregulated membrane dynamics that leads to cancer progression. We are particularly interested in alterations of how the cells internalize large molecules by endocytosis, how they degrade molecules in lysosomes, and how dynamics of the membrane that surrounds the nucleus is regulated.
We investigate genome dynamics with particular emphasis on oxidative stress, DNA base lesion repair and maintenance of epigenetic DNA methylation (epigenome stability).
The group has broad interest in atherosclerosis, inflammation and acute stroke, including multi-modal imaging methods such as MRI, PET and ultrasound.
CHARM is a research and service-user network of rehabilitation service research.
The research group studies mental illness among children and adolescents by using a variety of methods and perspectives.
The chromatin biology group focuses on epigenetic regulation in stem cells and cancer.
Human immunodeficiency virus (HIV), tuberculosis (TB), Hepatitis B (HBV), sepsis, influenza and COVID-19 are all globally dominant infections with increased or dysregulated inflammation important for the outcome of the disease.
The research profile is to test and develop new technologies in perioperative patient monitoring.
Our group conducts experimental and clinical research to study effects of hypoxia and other pulmonary diseases on heart and lungs.
Our research group is focusing its investigations on the main topic of ischemic heart disease, and extends its approach to adjacent research fields such as heart failure and atrial fibrillation.
Akershus University Hospital has since 2006 studied clinical communication.
The Research Group is conducting large randomized trials and observation studies to test and compare diagnostic and therapeutic clinical interventions in different areas of clinical medicine. The overarching goal is to find out what works and what does not. More than 300,000 patients are currently enrolled in studies run by the group.
The research group has several long-term projects ralted to clinical ethics in hospitals, community health services and mental health care.
Our overall goal is to establish early diagnostics and intervention for diseases that affect the nervous system.
The main purpose of our research group is to promote quality and gain new knowledge in clinical newborn medicine.
We perform translational research from basic radiology science to clinical research, pure clinical research and quality control studies in order to find new methods, improve methods, and control our work in order to keep high standards.
The research group studies causes and risk factors for suicide and self-harming behaviour, and evaluates and develops treatment methods.
The main aim of our research is clinical implementation and evaluation of new treatment, and diagnostic modalities for vitreoretinal disorders.
The main aim of the clinical studies in primary sclerosing cholangitis (PSC) is to determine effective means of treatment and diagnosis.
The research group carries out clinical research in virology and clinical vaccine trials. Our main focus is on viral hepatitis, enteric viruses, respiratory viruses, viral infections in immunosuppressed patients and in pregnancy.
Colorectal cancer (CRC) is common. Almost half of the patients proceed to metastatic disease, which for the great majority is incurable and unrecognizable by the immune system.
The main aim of our research is related to ear, hearing and cochlear implant; CI
Our overall aim is to understand how neuronal activity in the human brain is used for cognitive processes.
The research group conducts clinical and molecular genetic studies on colorectal cancer (crc).
We investigate communication in health care in general, and in cancer care and medical education in particular